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Osteoarthritis (OA), a prevalent chronic condition with a striking impact on life quality, 
represents an enormous societal burden that increases greatly as populations’ age. Yet 
no approved pharmacological intervention, biologic therapy or procedure prevents the 
progressive destruction of the OA joint. Based on bilayered structures that have been 
previously suggested for osteochondral (OC) applications (Oliveira et al 2006) and on 
the potential of  methacrylated gelatin (GelMA) and methacrylated gellan gum (MAGG) 
for different tissue engineering applications (Silva-Correia et al 2013, Tasoglu et al 
2014), we set a dynamic platform for the in vitro recreation of an OA 3D in vitro model. 
Since OA is an inflammatory and degenerative disorder affecting cartilage and 
subchondral bone, we created 6 hybrid formulations recreating a 3D controlled 
subchondral bone and cartilage integrated microenvironment. Fat pad adipose derived 
stem cells (ASCs) were isolated from Hoffa’s body obtained from healthy Patients, 
characterized by flow cytometry and their performance in the developed 3D structures 
assessed. GelMA formulation showed the best cell adhesion and proliferation, but the 
life-time of this one in culture is shorter due to the faster degradation in vitro comparing 
to MAGG based structures. According to this we proceeded with the best hybrid 
formulation, GelMA-MAGG 2:1, for OC co-differentiation using a dual-chamber 
bioreactor designed for the establishment of co-cultures in a single 3D structure 
(Canadas et al 2014). This approach solved challenges of 3D cell culture in interfaced 
tissues as OC and will ultimately be used for OA in vitro modeling. 
